DESCRIPTION

Thalidomide Capsules USP 50, 100,200 mg is an immunomodulatory agent.It is used in treatment of

MULTIPLE MYELOMA

Thalidomide Capsules in combination with dexamethasone is indicated for the treatment of patients with newly diagnosed multiple myeloma (MM).

ERYTHEMA NODOSUM LEPROSUM

Thalidomide Capsules is indicated for the acute treatment of the cutaneous manifestations of moderate to severe erythema nodosum leprosum (ENL). THALOMID is not indicated as monotherapy for such ENL treatment in the presence of moderate to severe neuritis. THALOMID is also indicated as maintenance therapy for prevention and suppression of the cutaneous manifestations of ENL recurrence.

There are many generic manufacturers in India who manufacture Thalidomide Capsules USP 50, 100,200 mg including United Biotech (p) Limited etc.

Siddha Global is Supplier,Exporter ,Wholesaler for Thalidomide Capsules USP 50, 100,200 mg in India.

THALIDOMIDE CAPSULES USP 50, 100,200 MG

₹0.00

數量

Side effects include

chest pain, sudden shortness of breath, coughing up blood;

pain or swelling in your arm, thigh, or calf;

fever, chills, body aches, flu symptoms, easy bruising or bleeding;

slow heartbeats, shallow breathing, feeling like you might pass out;

a red, blistering, peeling skin

Other serious side effects include

Teratogenicity

Thromboembolism

Drowsiness and Somnolence

Peripheral Neuropathy

Dizziness and Orthostatic Hypotension

Neutropenia

Increased HIV Viral Load

Bradycardia

Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis

Seizures

Tumor Lysis Syndrome

Hypersensitivity

THALIDOMIDE CAPSULES USP 50, 100,200 MG

PRODUCT INFO

ADDITIONAL INFORMATION

SIDE EFFECTS